Nathaniel Moore, DO in Lexington, VA - Medicare Emergency Medicine

Nathaniel Moore, DO is a medicare enrolled "Emergency Medicine" physician in Lexington, Virginia. He graduated from medical school in 2015 and has 9 years of diverse experience with area of expertise as Emergency Medicine. He is a member of the group practice Summit Medical Group Llc and his current practice location is 1 Health Cir, Lexington, Virginia. You can reach out to his office (for appointments etc.) via phone at (540) 458-3300.

Nathaniel Moore is licensed to practice in Virginia (license number 0102205155) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1164816500.

Contact Information

	Nathaniel Moore, DO
	1 Health Cir, Lexington, VA 24450-2448
	(540) 458-3300
	Not Available

Physician's Profile

Full Name	Nathaniel Moore
Gender	Male
Speciality	Emergency Medicine
Experience	9 Years
Location	1 Health Cir, Lexington, Virginia
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Nathaniel Moore graduated from medical school in 2015

NPI Data:

NPI Number: 1164816500
Provider Enumeration Date: 03/24/2015
Last Update Date: 11/21/2018

Medicare PECOS Information:

PECOS PAC ID: 8820305758
Enrollment ID: I20190826001489

Medical Identifiers

Medical identifiers for Nathaniel Moore such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1164816500	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207P00000X	Emergency Medicine	0102205155 (Virginia)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Cheyenne Regional Medical Center	Cheyenne, WY	Hospital
Ivinson Memorial Hospital	Laramie, WY	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Summit Medical Group Llc	5092094532	37

News Archive

SARS-CoV-2 mutations allow escape from clinical monoclonal antibodies

A new research paper recently uploaded to the preprint server bioRxiv by Jesse D. Bloom et al. (22nd Feb 2021) aims to map all of the currently circulating SARS-CoV-2 lineages with resistance towards LY-CoV555 and LY-CoV016, and document the specific mutations that confer resistance, ultimately suggesting that future monoclonal antibody cocktails should target a more diverse range of epitopes.

Novartis receives EC approval for Jakavi to treat myelofibrosis

Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.

Shutting off a critical cancer gene causes cancers in mice to self-destruct

Killing cancerous tumors isn't easy, as anyone who has suffered through chemotherapy can attest.

Novartis announces strategy to broaden patient reach and availability of medicines in sub-Saharan Africa

Novartis announced today a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa, which is home to the largest underserved patient population in the world.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Nathaniel Moore allows following entities to bill medicare on his behalf.

Entity Name	Summit Medical Group Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1457802993 PECOS PAC ID: 5092094532 Enrollment ID: O20161128000947

News Archive

SARS-CoV-2 mutations allow escape from clinical monoclonal antibodies

Novartis receives EC approval for Jakavi to treat myelofibrosis

Shutting off a critical cancer gene causes cancers in mice to self-destruct

Killing cancerous tumors isn't easy, as anyone who has suffered through chemotherapy can attest.

Novartis announces strategy to broaden patient reach and availability of medicines in sub-Saharan Africa

Entity Name	Ivinson Memorial Hospital
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1033628599 PECOS PAC ID: 8325304447 Enrollment ID: O20171213002021

SARS-CoV-2 mutations allow escape from clinical monoclonal antibodies

Novartis receives EC approval for Jakavi to treat myelofibrosis

Shutting off a critical cancer gene causes cancers in mice to self-destruct

Killing cancerous tumors isn't easy, as anyone who has suffered through chemotherapy can attest.

Novartis announces strategy to broaden patient reach and availability of medicines in sub-Saharan Africa

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Nathaniel Moore is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Nathaniel Moore, DO 4140 Shaw Blvd, Westminster, CO 80031-6918 Ph: (303) 917-4691	Nathaniel Moore, DO 1 Health Cir, Lexington, VA 24450-2448 Ph: (540) 458-3300

News Archive

SARS-CoV-2 mutations allow escape from clinical monoclonal antibodies

Novartis receives EC approval for Jakavi to treat myelofibrosis

Shutting off a critical cancer gene causes cancers in mice to self-destruct

Killing cancerous tumors isn't easy, as anyone who has suffered through chemotherapy can attest.

Novartis announces strategy to broaden patient reach and availability of medicines in sub-Saharan Africa

Emergency Medicine Doctors in Lexington, VA

John M Sheridan, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 25 Northridge Ln, Lexington, VA 24450 Phone: 540-464-8700 Fax: 540-464-1362
Patricia Schirmer, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 650 N Lee Hwy, Suite 2, Lexington, VA 24450 Phone: 540-463-0951 Fax: 540-463-0954
Justin Lackey, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Health Cir, Lexington, VA 24450 Phone: 540-458-3300
Daniel Owen Lareaux, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Health Cir, Lexington, VA 24450 Phone: 540-458-3300 Fax: 540-458-3366
Dr. Stanley E Heatwole, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Health Cir, Lexington, VA 24450 Phone: 540-458-3300 Fax: 540-458-3366
Colleen Arnold, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Comfort Way Ste 1, Lexington, VA 24450 Phone: 540-463-3381 Fax: 540-463-3477

Nathaniel Moore, DO - Medicare Emergency Medicine in Lexington, VA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

SARS-CoV-2 mutations allow escape from clinical monoclonal antibodies

Novartis receives EC approval for Jakavi to treat myelofibrosis

Shutting off a critical cancer gene causes cancers in mice to self-destruct

Novartis announces strategy to broaden patient reach and availability of medicines in sub-Saharan Africa

Medicare Reassignments

SARS-CoV-2 mutations allow escape from clinical monoclonal antibodies

Novartis receives EC approval for Jakavi to treat myelofibrosis

Shutting off a critical cancer gene causes cancers in mice to self-destruct

Novartis announces strategy to broaden patient reach and availability of medicines in sub-Saharan Africa

SARS-CoV-2 mutations allow escape from clinical monoclonal antibodies

Novartis receives EC approval for Jakavi to treat myelofibrosis

Shutting off a critical cancer gene causes cancers in mice to self-destruct

Novartis announces strategy to broaden patient reach and availability of medicines in sub-Saharan Africa

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

SARS-CoV-2 mutations allow escape from clinical monoclonal antibodies

Novartis receives EC approval for Jakavi to treat myelofibrosis

Shutting off a critical cancer gene causes cancers in mice to self-destruct

Novartis announces strategy to broaden patient reach and availability of medicines in sub-Saharan Africa

Emergency Medicine Doctors in Lexington, VA